𝔖 Bobbio Scriptorium

✦ LIBER ✦

174 RISK FACTORS AND CLINICAL INFLUENCE OF EARLY CALCINEURIN INHIBITOR-INDUCED NEUROTOXICITY IN LIVER TRANSPLANTATION

✍ Scribed by D.C. Balderramo; J. Prieto; C. Fondevila; M. Navasa

Book ID: 117376100
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 57 KB
Volume: 48
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(08)60176-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical trial: switch to combined mycop

Clinical trial: switch to combined mycophenolate mofetil and minimal dose calcineurin inhibitor in stable liver transplant patients – assessment of renal and allograft function, cardiovascular risk factors and immune monitoring

✍ V. R. CICINNATI; Z. YU; C. G. KLEIN; G. C. SOTIROPOULOS; F. SANER; M. MALAGÓ; A. 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 238 KB

Impact of combined mycophenolate mofetil

Impact of combined mycophenolate mofetil and low-dose calcineurin inhibitor therapy on renal function, cardiovascular risk factors, and graft function in liver transplant patients: Preliminary results of an open prospective study

✍ S. Beckebaum; V.R. Cicinnati; C.G. Klein; E. Brokalaki; Z. Yu; M. Malago; A. Fri 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 136 KB